Roivant Sciences Ltd. operates as a healthcare company. The Company offers investigational drugs in development for therapeutic areas such as dermatology, immunology, and respiratory diseases, as well as provides healthcare technologies which help healthcare institutions share and aggregate data. Roivant Sciences provides services worldwide.

Investor Day 2025

43rd Annual J.P. Morgan Healthcare Conference

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Roivant Sciences Ltd (ROIV US)

Investor Day 2025

43rd Annual J.P. Morgan Healthcare Conference

Q3 2026

Jefferies London Healthcare Conference 2025

Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)